Premium
Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition
Author(s) -
DOUZENIS A.,
MICHOPOULOS I.,
ECONOMOPOULOS T.,
LYKOURAS L.,
SOLDATOS C.R.
Publication year - 2007
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/j.1365-2354.2006.00735.x
Subject(s) - medicine , alprazolam , olanzapine , terminally ill , psychomotor agitation , parenteral nutrition , anesthesia , intensive care medicine , psychiatry , nursing , palliative care , schizophrenia (object oriented programming) , anxiety
This paper reports the case of a 64‐year‐old man who was receiving parenteral nutrition after repeated operations due to stomach cancer. Olanzapine (orally disintegrating tablets) in combination with alprazolam was used successfully to relieve this terminally ill patient’s anxiety and tension improving his relationship with his physicians and his daily life.